Adjuvant High-Dose Intravenous Immunoglobulin Therapy Can Be Easily and Safely Introduced as an Alternative Treatment in Patients with Severe Pemphigus Vulgaris: A Retrospective Preliminary Study

Author： Michele Davide Mignogna  

Publisher： Adis International

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.9, Iss.5, 2008-01, pp. : 323-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transient Efficacy of Double High-Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation, Immunoglobulin, Thalidomide, and Bortezomib in the Treatment of Scleromyxedema

By Ataergin Selmin  

American Journal of Clinical Dermatology, Vol. 9, Iss. 4, 2008-01 ,pp. : 271-273

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Cyclophosphamide, Azathioprine, and Cyclosporine (Ciclosporin) as Adjuvant Drugs in Pemphigus Vulgaris

By Olszewska Malgorzata  

American Journal of Clinical Dermatology, Vol. 8, Iss. 2, 2007-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

Treatment of Pemphigus Vulgaris: Current and Emerging Options

By Shih Wei Yeh   Sami Naveed   Ahmed Razzaque A.  

American Journal of Clinical Dermatology, Vol. 6, Iss. 5, 2005-01 ,pp. : 327-342

Adis International

Access to resources Recommend Favorite

Variations in Serum Hemoglobin, Albumin, and Electrolytes in Patients Receiving Intravenous Immunoglobulin Therapy: A Real Clinical Threat?

By Mignogna Michele D.  

American Journal of Clinical Dermatology, Vol. 8, Iss. 5, 2007-01 ,pp. : 291-299

Adis International

Access to resources Recommend Favorite

Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders

By Larroche C.  

BioDrugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 47-55

Adis International

Access to resources Recommend Favorite